Please login to the form below

Not currently logged in


This page shows the latest Euthyrox news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA to make $3m payout to patients after drug formulation complaints

Merck KGaA to make $3m payout to patients after drug formulation complaints

When former health minister Agnès Buzyn made the original formula, Euthyrox, available after a public outcry, half of the 130, 000 boxes that were put back on pharmacy shelves sold out

Latest news

  • Merck Serono to invest €150m in China R&D

    The Swiss-based company's key products Erbitux (cancer), Rebif (multiple sclerosis), Gobal-f (infertility), Saizen (endocrine and metabolic disorders) and Concor and Euthyrox (cardiometabolic diseases) are already available in the

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts


Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
The rise of digital healthcare – fuelled by open innovation in healthtech hubs
How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...